Cardinal Health (CAH) Cash & Equivalents (2009 - 2026)

Cardinal Health has reported Cash & Equivalents for 18 years, with the latest figure at $3.9 billion in Q1 2026.

• Quarterly Cash & Equivalents rose 18.37% year-over-year to $3.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 billion (up 18.37% YoY) and the FY2025 annual result came in at $3.9 billion, down 24.53% from the prior year.
• Cash & Equivalents advanced to $3.9 billion in Q1 2026 per CAH's latest filing, from $2.8 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $5.1 billion in Q2 2024 and troughed at $2.4 billion in Q1 2022.
• A 5-year average of $3.8 billion and a median of $3.9 billion in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 32.67% in 2022, then surged 69.35% in 2023.
• Over 5 years, Cash & Equivalents stood at $3.7 billion in 2022, then increased by 25.64% to $4.6 billion in 2023, then retreated by 17.01% to $3.8 billion in 2024, then slipped by 27.11% to $2.8 billion in 2025, then surged by 41.77% to $3.9 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $3.9 billion, $2.8 billion, and $4.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.